- Pharmaceutical Products
- Products By Brand Name
- Products By Dosage Form
- Products By Generic Name
- Products By Therapeutic Class
Find a product
Find Generic
Renexin
Ranolazine
Description:
Ranolazine is a new class of antianginal drugs and it is a selective late-sodium current inhibitor.
Ranolazine is a new class of antianginal drugs and it is a selective late-sodium current inhibitor.
Indications:
Ranolazine is indicated for the treatment of chronic angina.
Ranolazine is indicated for the treatment of chronic angina.
Mode of Action:
Ranolazine inhibits persistent or late inward sodium current (INa) in heart muscle in a variety of voltage-gated sodium channels. Inhibiting that current leads to reductions in intracellular calcium levels. This in turn leads to reduced tension in the heart wall, leading to reduced oxygen requirements for the muscle and relief from myocardial ischemia.
Ranolazine inhibits persistent or late inward sodium current (INa) in heart muscle in a variety of voltage-gated sodium channels. Inhibiting that current leads to reductions in intracellular calcium levels. This in turn leads to reduced tension in the heart wall, leading to reduced oxygen requirements for the muscle and relief from myocardial ischemia.
Different Dosages from Renexin
Other Brands From Same Therapeutic Class
